Tag Archives: Anti-Malarial

FDA wants Ghanaian pharmaceuticals to be WHO compliant

The FDA has asked the Pharmaceutical Manufacturers Association of Ghana to devise an action plan that would see its members become WHO compliant.  A very important first step towards creating a culture of compliance, standards and uniformity in the region.  The Ghana pharmaceutical landscape is a success story in Western Africa where overall quality from […]

A case for investment in local pharma in Africa By Brian Ngwatu

Here is a blog written by Brian Ngawatu on the Global Health Corps Blog The Article can be found here: http://ghcorps.org/a-case-for-investment-in-local-pharma-in-africa/ With 11% of the world’s population, and 25% of the global disease burden (and if I may add, 1% of the global health care expenditure), Africa never ceases to amaze many. Add to this, […]

AGP | The New Brand

New Look of AGP AGP (African Global Pharma) is proud to unveil its new brand and look. We have been working hard to ensure that the values and AGP Cares Philosophy, that we so dearly adhere to, are reflected in the face of the company.  AGP is a dynamic and progressive company committed to improving […]

Ghana: Towards Universal Health Coverage

By Patricio V. Marquez As a newcomer in my new post in Accra, I am starting to learn about Ghana’s achievements and challenges. I have been impressed with some innovative policies and measures adopted to address difficult development challenges in the social sectors. …read more Source: Word Bank Health     

AGP has commenced production of the anti-malarial pharmaceutical Globartem®.

Oct 30, 2012 African Global Pharma Corp.(AGP) has commenced production of the anti-malarial pharmaceutical Globartem®. Globartem® is indicated for the treatment of uncomplicated malaria caused by multiple drug resistant strains of p. falciparum. AGP will produce the medicine in tablet form including a dispersible tablet for pediatric use. Each tablet contains Artemether 20mg and Lumefantrine […]